Not available
Quote | Celgene Corporation (NASDAQ:CELG)
Last: | $ |
---|---|
Change Percent: | 0.88% |
Open: | $101.11 |
Close: | $101.86 |
High: | $102.02 |
Low: | $101.11 |
Volume: | 2,053,419 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Celgene Corporation (NASDAQ:CELG)
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
Bristol Myers Squibb has an impressive portfolio of assets and strong financials. The company has recently wrapped up large acquisitions. The company is focused on redeveloping its portfolio and expects a massive increase in revenue from new businesses. Going forward, we expect sh...
Message Board Posts | Celgene Corporation (NASDAQ:CELG)
Subject | By | Source | When |
---|---|---|---|
Better Buy: Celgene vs. Gilead Sciences | BottomBounce | investorshub | 10/24/2020 12:38:18 PM |
Sorry, dont know | patrickjishere | investorshub | 02/18/2019 10:31:14 PM |
Do you or anyone here know the tax | rosemountbomber | investorshub | 02/18/2019 10:08:04 PM |
Advances in Cancer Drugs Fuel Deal -- WSJ | TheFinalCD | investorshub | 01/04/2019 2:09:31 PM |
Yep, I like $BMY and the deal. | patrickjishere | investorshub | 01/03/2019 7:24:29 PM |
News, Short Squeeze, Breakout and More Instantly...